Immunologic factors in implantation

Infertility and Reproductive Medicine Clinics of North America

Volumn 12, Issue 2, 2001, Pages 315-337

  Ghazeeri, G S ^a   Clark, D A ^a   Kutteh, W H ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD16 ANTIGEN; CD56 ANTIGEN; COLONY STIMULATING FACTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; PHOSPHOLIPID ANTIBODY; PREGNANCY ASSOCIATED PROTEIN; SOMATOMEDIN BINDING PROTEIN; THYROID ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLOIMMUNITY; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONCEPTION; CYTOKINE RELEASE; EMBRYO DEATH; EMBRYO MORTALITY; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; IMPLANTATION; LEUKOCYTE FUNCTION; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; NIDATION; NONHUMAN; REVIEW; SPONTANEOUS ABORTION; TROPHOBLAST;

EID: 0035070515     PISSN: 10479422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Monoclonal antiphosphatidyl serine antibody inhibits intercellular fusion of the choriocarcinoma line
2. Development of cytotrophoblast columns from explanted first-trimester human placental villi: Role of fibronectin and integrin α5β1
3. Immunohistochemical study of the distribution of secretory component and IgA in the normal and diseased uterine mucosa
4. Reproductive immunology and its disorders
5. The effect of endometriosis on implantation results from the Yale University In Vitro Fertilization and Embryo Transfer Program
6. High pregnancy rates after oocyte and embryo donation
7. Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer
8. Antiphospholipid antibodies and human reproductive failure
9. Host responses to intrauterine tissue, cellular and fetal allografts
10. Tumor necrosis factor α binding to human and mouse trophoblast
11. The impact of embryonic development and endometrial maturity on the timing of implantation
12. Antiphospholipid antibodies in women having in vitro fertilization
13. Macrophage populations in the human placenta and amniochorion
14. Granulated lymphocytes in human endometrium: Histochemical and immunochemical studies
15. Expression of MHC II gene products by macrophages in human uteroplacental tissue
16. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous trophoblast explants
17. Adaptive interactions between cytokines and the hypothalamic-pituitary-gonadal axis
18. Effect of paternal leukocyte immunization on implantation after biochemical pregnancies and repeated failure of embryo transfer
19. Control of fetal survival in CBA/JxDBA/2 mice by lymphokine therapy
20. Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization
21. A fresh look at the causes and treatments of recurrent miscarriage, especially its immunological aspects
22. Hard science versus phenomenology in reproductive immunology
23. Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at the uterine level
24. Stress-triggered abortion in mice is prevented by alloimmunization
25. CD56+ lymphoid cells in human first trimester decidua as a source of novel pregnancy transforming growth factor β2-related immunosuppressive factors
26. Antiphospholipid antibodies associated with implantation failure after IVF/ET
27. Intravenous immunoglobulin for in vitro fertilization failure
28. Parental human leukocyte antigens and implantation failure after in vitro fertilization
29. Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients
30. Intravenous immunoglobulin IVIg in the prevention of implantation failures
31. Clinical approaches to increasing uterine receptivity during human implantation
32. Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction
33. Structural interactions of trophoblast and uterus during hemochorial placenta formation
34. Cytokine activity against trophoblast and choriocarcinoma cells of large granular lymphocytes from human early pregnancy decidua
35. Human cytotrophoblast differentiation/invasion is abnormal in preeclampsia
36. Administration of thymocytes derived from nonpregnant mice induces an endometrial receptive state and leukemia inhibitory factor expression in the uterus
37. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki67
38. Autoimmunity and reproduction
39. Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: A prospective study
40. Membrane phenotype and expression of perforin and serine esterases by CD5 peripheral blood and decidual granular lymphocyte-derived clones
41. Expression of functional molecules by human CD3-decidual granular leukocyte clones
42. Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro
43. T helper type 1 immunity to trophoblast in women with recurrent spontaneous abortion
44. Antiphospholipid antibodies and in vitro fertilization success: A meta analysis
45. Macrophages in the uterus and placenta
46. Uterine macrophages and environmental programming for pregnancy success
47. Cytotoxic activity of endometrial granulated lymphocytes during the menstrual cycle in humans
48. Endometrial large granular lymphocytes: Correlation with IVF outcome
49. Murine embryos as a direct target for some human autoantibodies in vitro
50. The immuno-cytochemical distribution of leukocytic subpopulations in human endometrium
51. Interleukin-1β and interleukin-1α may affect the implantation rate of patients undergoing in vitro fertilization-embryo transfer
52. Monoclonal antiphosphatidyl serine antibody against human first-trimester placental trophoblasts
53. Embryonic signals and the initiation of blastocyst implantation
54. Immunohistochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle
55. Expression of perforin granzyme-A and TIA-1 by human uterine CD56+ NK cells implies they are activated and capable of effector functions
56. Intravenous immunoglobulins increase pregnancy rate in an IVF program
57. Endometrial lymphoid tissue in the timed endometrial biopsy: Morphometric and immunohistochemical aspects
58. Lymphoid tissue in the endometrium of women with unexplained infertility: Morphometric and immunohistochemical aspects
59. Midfollicular anticardiolipin and antiphosphatidyl serine antibody titers do not correlate with in vitro fertilization outcome
60. Antiphospholipid antibodies and reproduction
61. Secretory immune system of the female reproductive tract: I. Immunoglobulin and secretory components containing cells
62. Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction
63. Effect of antiphospholipid antibodies in women undergoing in vitro fertilization: Role of heparin and aspirin
64. Suppression of lymphocyte alloreactivity by early gestational human decidua. II. Characterization of the suppressor mechanisms
65. A subset of patients with recurrent spontaneous abortions is deficient in transforming growth factor β2 producing suppressor cells in uterine tissue near the placental attachment site
66. Macrophages and other migratory cells in endometrium relevant to implantation
67. Antigen expression by cells near the maternal fetal interface
68. Endometrial integrins and the establishment of uterine receptivity
69. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast
70. Sensitivity of the activated partial thromboplastin time, the dilute Russell's viper venom time, and the kaolin clotting time for the detection of the lupus anticoagulant: A direct comparison using plasma dilutions
71. Effects of interleukin-6 (IL-6) on cytotrophoblast cells
72. MUC1 and endometrial receptivity
73. Comparison of blastocyst transfer with day 3 embryo transfer in similar patient populations
74. Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T cell response
75. The potential role of stem cell factor and its receptor c-kit in the mouse blastocyst implantation
76. Immunogenic and serological investigations in non pregnant and in pregnant women with a history of RSA
77. The effect of leukemia inhibitory factor on trophoblast differentiation: A potential role in human implantation
78. The CD94/NKG2-A inhibitory receptor couple is involved in natural killer cell-mediated recognition of cells expressing HLA-G
79. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions
80. A pregnancy defect in the osteopetrotic op/op mouse demonstrates the requirement for CSF-1 in female fertility
81. Uterine receptivity for nidation
82. Pregnancy loss in the antiphospholipid antibody syndrome: A possible thrombogenic mechanism
83. Antiphospholipid immunoglobulin s G antibodies reduce annex in-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi
84. Pregnancy and birth rates after oocyte donation
85. Isolation and functional studies of granulated lymphocytes in first trimester decidua
86. The role of cytokines in gestation
87. Antiphospholipid antibodies and placental development
88. IL-10 is an autocrine inhibitor of human placenta trophoblast MMP-9 production and invasion
89. Investigation of H-2 and non-H-2 antigens on the murine blastocyst
90. Immunohistochemical localization of transforming growth factor-β in human implantation sites
91. Leukemia inhibitory factor in human reproduction
92. Cytokines and implantation
93. High fecunidity rates following antiphospholipid antibody seropositive women treated with heparin and aspirin
94. The selective use of heparin/aspirin therapy alone or in combination with intravenous immunoglobulin G in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization
95. A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies
96. Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium
97. CD94/NKG2 is the predominant inhibiting receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells
98. Defection of at risk pregnancy by means of highly sensitive assays for thyroid autoantibodies
99. Variation during the menstrual cycle of immune cell populations in human endometrium
100. Endometrial leukocytes are altered numerically and functionally in women with implantation defects
101. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor
102. Molecular control of the implantation window
103. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion
104. Seminal transforming growth factor-β1 stimulated granulocyte-macrophage colony stimulating factor production and inflammatory cell recruitment in the murine uterus
105. Quantitative analysis of T lymphocyte subsets in pregnant and non pregnant human endometrium
106. + CTL activity within the human female reproductive tract: Influence of stage of the menstrual cycle and menopause
107. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome
108. Analysis of HLA-G mRNA in human placental and extraplacental membranes and cells by in situ hybridization